Donor program for fecal microbiota transplantation: A 3-year experience of a large-volume Italian stool bank

SARS-CoV-2 vaccines and donor recruitment for FMT

(2021) Gianluca Ianiro et al.   Lancet Gastroenterology & Hepatology

Evidence for gastrointestinal infection of SARS-CoV-2

(2020) Fei Xiao et al.   GASTROENTEROLOGY

Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel

(2020) Gianluca Ianiro et al.   Lancet Gastroenterology & Hepatology

Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic

(2020) Gianluca Ianiro et al.   GUT

Faecal microbiota transplantation for Clostridioides difficile infection: Four years’ experience of the Netherlands Donor Feces Bank

(2020) Elisabeth M Terveer et al.   United European Gastroenterology Journal

International consensus conference on stool banking for faecal microbiota transplantation in clinical practice

(2019) Giovanni Cammarota et al.   GUT

Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics

(2019) Gianluca Ianiro et al.   ANNALS OF INTERNAL MEDICINE

Donor Screening for Fecal Microbiota Transplantation

(2019) Zain Kassam et al.   NEW ENGLAND JOURNAL OF MEDICINE

Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant

(2019) Zachariah DeFilipp et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases

(2019) Huihui Xu et al.   Journal of Immunology Research

Healthcare personnel intestinal colonization with multidrug-resistant organisms

(2018) B.K. Decker et al.   CLINICAL MICROBIOLOGY AND INFECTION

Consensus report: faecal microbiota transfer - clinical applications and procedures

(2016) J. König et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Recurrent Clostridium difficile infection: From colonization to cure

(2015) Kelsey Shields et al.   ANAEROBE

Fecal Microbiota Transplantation forClostridium difficileInfection

(2015) Dimitri Drekonja et al.   ANNALS OF INTERNAL MEDICINE

Risk Factors and Outcomes for Bloodstream Infections Secondary to Clostridium difficile Infection

(2015) Marco Falcone et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Establishing a Fecal Microbiota Transplant Service for the Treatment ofClostridium difficileInfection

(2015) Samuel P. Costello et al.   CLINICAL INFECTIOUS DISEASES

Recurrent Clostridium difficile infection is associated with increased mortality

(2015) M.A. Olsen et al.   CLINICAL MICROBIOLOGY AND INFECTION

Donor Recruitment for Fecal Microbiota Transplantation

(2015) Sudarshan Paramsothy et al.   INFLAMMATORY BOWEL DISEASES

Burden of Clostridium difficile Infection in the United States

(2015) Fernanda C. Lessa et al.   NEW ENGLAND JOURNAL OF MEDICINE

Therapeutic Modulation of Gut Microbiota: Current Clinical Applications and Future Perspectives

(2014) Gianluca Ianiro et al.   CURRENT DRUG TARGETS

Guidelines for Diagnosis, Treatment and Prevention of Clostridium difficile Infections

(2013) Christina M Surawicz et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

European Society of Clinical Microbiology and Infectious Diseases: Update of the Treatment Guidance Document for Clostridium difficile Infection

(2013) S.B. Debast et al.   CLINICAL MICROBIOLOGY AND INFECTION

Burden of Clostridium difficile on the Healthcare System

(2012) Erik R. Dubberke et al.   CLINICAL INFECTIOUS DISEASES